Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Imatinib Mesylate × Breast × Clear all

Phase

Phase 2 6 Phase 1 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13 Myeloid 11 Sarcoma 3 Gastrointestinal 3 Lymphoid 2 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Letrozole 23 Docetaxel 17 Cyclophosphamide 13 Zoledronic Acid 12 Trastuzumab 12 Anastrozole 12 exemestane 11 Tamoxifen 11 Paclitaxel 11 Capecitabine 10 Fulvestrant 8 Epirubicin 8 pegfilgrastim 7 Saline Solution 7 Bupivacaine 7 pertuzumab 6 liposomal doxorubicin 6 abemaciclib 6 Sodium Chloride 6 Filgrastim 6 Carboplatin 6 pegylated granulocyte colony-stimulating factor 5 palbociclib 5 Ropivacaine 5 Dexmedetomidine 5 Bevacizumab 5 ribociclib 4 eribulin 4 Vinorelbine 4 Tranexamic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00372476 2017-02-07

INV181

Novartis

Phase 4 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡